Corporate Profile for Chromagen Inc., dated Sept. 8, 1995.--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services. These include Dow Jones News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog, NewsNet, America OnLine, CompuServe, Delphi, Individual's HeadsUp and First!, Desktop Data's NewsEdge, UMI UMI University Microfilms International UMI United States Minor Outlying Islands (ISO Country code) UMI University of Miami UMI Universal Management Infrastructure (IBM) Data Courier, NewsBank, Information Access Company and many others. -0- Published date: Sept. 8, 1995 Company name: Chromagen Inc.
Address: 10441 Roselle St., Suite A
San Diego, Calif. 92121
Telephone No.: 619/558-1456 Fax No.: 619/558-7166 Chief Executive Officer: Christen Hedrick Public Relations Contact: Christen Hedrick Business number: 619/558-1456 Home number: 619/436-4475 Company description: Chromagen is an emerging in vitro diagnostics In vitro diagnostic (IVD) tests are medical tests conducted in a test tube, or more generally in a controlled environment outside a living organism. In vitro means in glass in Latin. company with patented detection and delivery technologies which overcome the limitations of existing systems, thereby creating a new generation of nucleic acid and immunoassay Immunoassay An assay that quantifies antigen or antibody by immunochemical means. The antigen can be a relatively simple substance such as a drug, or a complex one such as a protein or a virus. products. The company's scientific core includes broadly enabling platform technologies based upon 1) the molecular biology, chemistry and detection of RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic and DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. , 2) the clinical chemistries of infectious and genetic diseases, and 3) the design of instruments and software for clinical use. Chromagen's immediate objectives are to develop completely integrated, nucleic acid-based diagnostic systems for use in the prevention, early detection and control of significant human, veterinary, food and agricultural disorders. Chromagen was founded in 1992 by Dr. Michael Conrad, who is responsible for the development of the company's proprietary technology. Chromagen's management team has considerable experience and success in the invention, development and introduction of novel tests to the clinical diagnostic market. To date, the company has raised $2 million in funding from corporate, venture capital, government grants and private sources and has signed a Joint Development Agreement with 3M Co. Chromagen is currently developing assays for tuberculosis, chlamydia chlamydia (kləmĭd`ēə), genus of microorganisms that cause a variety of diseases in humans and other animals. Psittacosis, or parrot fever, caused by the species Chlamydia psittaci, , cryptosporidium cryptosporidium (krĭp'tōspərĭd`ēəm), genus of protozoans having at least four species; they are waterborne parasites that cause the disease cryptosporidiosis. and coccidiosis coccidiosis /coc·cid·i·o·sis/ (kok-sid?e-o´sis) infection by coccidia. In humans, applied to the presence of Isospora hominis or I. belli in stools; it is often asymptomatic, rarely causing a severe watery mucous diarrhea. , and is actively seeking development and marketing partners in the human and animal health markets. CONTACT: Chromagen Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion